-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Market Perform on Ionis Pharmaceuticals, Raises Price Target to $61

Benzinga·09/04/2026 15:12:41
語音播報
BMO Capital analyst David Lebowitz maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Market Perform and raises the price target from $60 to $61.